News tagged with virologic response
Continuing analysis of an HIV vaccine trial undertaken in Thailand is yielding additional information about how immune responses were triggered and why the vaccine did not protect more people.
HIV & AIDS May 06, 2013 | not rated yet | 0 |
Researchers have discovered the mechanism behind one of the Ebola virus' most dangerous attributes: its ability to disarm the adaptive immune system.
Medical research May 02, 2013 | 5 / 5 (5) | 0 |
(HealthDay)—A new vaccination approach may provide protection against genital herpes as well as other sexually transmitted infections, including HIV, according to a new study involving mice.
Medical research Oct 17, 2012 | 5 / 5 (5) | 0 |
(HealthDay)—Sofosbuvir seems to be a promising treatment option for patients with chronic hepatitis C virus (HCV) infection, according to two studies published online April 23 in the New England Journal of ...
Diseases, Conditions, Syndromes Apr 23, 2013 | 4 / 5 (1) | 0 |
People with a rare genetic trait who are infected with HIV progress more slowly to AIDS than others. But even within this group, there are wide variations in time to progression. A new study illustrates in detail how the ...
HIV & AIDS Sep 19, 2012 | not rated yet | 0
One of the big mysteries of AIDS is why some HIV-positive people take more than a decade to progress to full-blown AIDS, if they progress at all.
HIV & AIDS Sep 19, 2012 | 5 / 5 (1) | 0 |
A team of scientists led by virologists Prof. Oliver T. Fackler and Prof. Oliver T. Keppler from Heidelberg University Hospital have decoded a mechanism used by the human immune system to protect itself from HIV viruses. ...
HIV & AIDS Oct 02, 2012 | 5 / 5 (1) | 0
(HealthDay)—For patients with hepatitis C virus (HCV) treated with pegylated interferon-alpha and ribavirin (P/R), drinking patterns and the amount of alcohol consumed before treatment do not impact treatment ...
Diseases, Conditions, Syndromes Oct 11, 2012 | not rated yet | 0
(HealthDay)—For untreated patients with hepatitis C virus (HCV), treatment with an oral nucleotide inhibitor of HCV polymerase, sofosbuvir, plus ribavirin seems effective for genotypes 1, 2, and 3; and ...
Diseases, Conditions, Syndromes Jan 03, 2013 | not rated yet | 0
University of Washington researchers have made a discovery that sheds light on why the human body is unable to adequately fight off HIV infection.
HIV & AIDS Jul 12, 2012 | 5 / 5 (1) | 0 |
A Loyola University Chicago Stritch School of Medicine study could lead to improved gene therapies for conditions such as heart disease and cancer as well as more effective vaccines for tuberculosis, malaria and other diseases.
Cardiology Oct 12, 2011 | not rated yet | 0 |
A recent clinical trial found that the adult antiviral drug, tenofovir disoproxil fumarate (tenofovir DF), is safe and effective in treating adolescents with hepatitis B virus (HBV). Trial results published in the December ...
Diseases, Conditions, Syndromes Dec 05, 2012 | 5 / 5 (1) | 0 |
Despite the fact that hepatitis C virus (HCV) persists chronically in about 80 percent of those infected, some liver cells remain free of the virus even after many years. Now Sung Key Jang of Pohang University of Science ...
Diseases, Conditions, Syndromes Sep 19, 2011 | not rated yet | 0
(Medical Xpress) -- Researchers in the Department of Virology and the Clinical Department of Thoracic Surgery at the MedUni Vienna have demonstrated that the risk of cytomegalovirus infection following lung ...
Other Jun 25, 2012 | not rated yet | 0
British researchers have identified specific resistance mutations for two classes of p7 inhibitor, which may explain their lack of effectiveness in clinical trials combined with current standard of care. Study results support ...
Diseases, Conditions, Syndromes Jun 28, 2011 | not rated yet | 0